论文部分内容阅读
呋咱甲氢龙(furazabol),又名去脂舒,是一种蛋白同化激素,近年来,国外较多报道用于治疗高脂血症。我们于1978年12月~1979年4月间曾用于治疗30例高脂血症患者,取得了较好的疗效,现报道如下。临床资料30例高脂血症患者,男22例,女8例,年龄为30~72岁,均按上海市冠心病协作组拟订的“血脂增高程度及其分型”进行诊断。30例中,包括高胆固醇血症者26例,其中属轻度增高者9例,中度增高者14例及重度增高者3例。高甘油三酯血症者26例,其中属轻度增高者8例,中度增高者2例及重度增高者16例。伴冠心病者15例,高血压病者16例。治疗方法
Furosemide Hydrochloride (furazabol), also known as defatted Shu, is a protein anabolic hormone, in recent years, more reports abroad for the treatment of hyperlipidemia. We in December 1978 ~ April 1979 was used to treat 30 patients with hyperlipidemia, and achieved good results, are reported below. Clinical data 30 cases of hyperlipidemia patients, 22 males and 8 females, aged 30 to 72 years old, according to Shanghai co-operation of coronary heart disease group developed “blood lipid levels and its classification ” for diagnosis. Thirty cases, including hypercholesterolemia in 26 cases, of which mild increase in 9 cases, moderately increased in 14 cases and severe increased in 3 cases. Hypertriglyceridemia in 26 cases, of which there is a slight increase in 8 cases, moderately increased in 2 cases and severe hyperplasia in 16 cases. 15 cases with coronary heart disease, hypertension in 16 cases. treatment method